SML1854
巴诺蒽醌 二盐酸盐
≥98% (HPLC)
别名:
1,4-双[[[2-（二甲基氧化氨基）乙基]氨基] -5,8-二羟基-9,10-蒽二酮, AQ4N 二盐酸盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C22H28N4O6 · 2HCl
化学文摘社编号:
分子量:
517.40
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
巴诺蒽醌 二盐酸盐, ≥98% (HPLC)
InChI
1S/C22H28N4O6.2ClH/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30;;/h5-8,23-24,27-28H,9-12H2,1-4H3;2*1H
SMILES string
O=C1C2=C(C(NCC[N+](C)([O-])C)=CC=C2NCC[N+]([O-])(C)C)C(C3=C(O)C=CC(O)=C31)=O.[H]Cl.[H]Cl
InChI key
SBWCPHUXRZRTDP-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
blue
solubility
H2O: 3 mg/mL, clear (warmed)
storage temp.
2-8°C
Quality Level
相关类别
Application
Banoxantrone Dihydrochloride作为有机配体用于自组装金属-有机配位纳米粒子(Cu–OCNP/Lap)的合成。它也被用于制备超分子功能化氧化石墨烯，用于癌症的缺氧活化化疗。
Biochem/physiol Actions
Banoxantrone Dihydrochloride可增强辐射所致的抗肿瘤作用。
巴诺蒽醌（AQ4N）是拓扑异构酶II抑制剂AQ4（生物还原性AQ4前体）的一种低氧激活前药。
拓扑异构酶II抑制剂AQ4的低氧激活前药
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
O P Friery et al.
British journal of cancer, 82(8), 1469-1473 (2000-04-26)
The ability of the bioreductive drugs AQ4N and tirapazamine to enhance the anti-tumour effect of cyclophosphamide was assessed in three murine tumour models. In male BDF mice implanted with the T50/80 mammary carcinoma, AQ4N (50-150 mg kg(-1)) in combination with
Qi Zhang et al.
Scientific reports, 12(1), 6294-6294 (2022-04-21)
Spike-mediated entry of SARS-CoV-2 into human airway epithelial cells is an attractive therapeutic target for COVID-19. In addition to protein receptors, the SARS-CoV-2 spike (S) protein also interacts with heparan sulfate, a negatively charged glycosaminoglycan (GAG) attached to certain membrane
Olivier Trédan et al.
Cancer research, 69(3), 940-947 (2009-01-30)
Hypoxic tumor cells are likely to be resistant to conventional chemotherapy, in large part because many anticancer drugs are unable to penetrate into poorly oxygenated tumor tissue. Here, we used quantitative immunofluorescence to study the distribution of mitoxantrone and AQ4N
Yuan-Fu Ding et al.
Biomaterials science, 9(10), 3804-3813 (2021-04-22)
Nano-graphene oxide (NGO) has attracted increasing attention as an advanced drug delivery system. However, the current surface functionalization and drug-loading of NGO either rely on π-π stacking that is limited to aromatic molecules, or covalent conjugation that requires tedious synthesis.
Heather Nesbitt et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 23(7), 1797-1808 (2016-10-05)
Purpose: To understand the role of hypoxia in prostate tumor progression and to evaluate the ability of the novel unidirectional hypoxia-activated prodrug OCT1002 to enhance the antitumor effect of bicalutamide.Experimental Design: The effect of OCT1002 on prostate cancer cells (LNCaP
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持